HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinibY. Wang, Fred R. Hirsch, Christopher J. Rivard et al.|Annals of Oncology|2018Cited by 217
Phase separation of EML4–ALK in firing downstream signaling and promoting lung tumorigenesisZhen Qin, Hongbin Ji|Cell Discovery|2021Cited by 76
Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic targetHua Wang, Hongbin Ji, Shijie Tang et al.|National Science Review|2024Cited by 7